CTO Certest Pharma
Certest Biotec
Zaragoza, Spain
Javier holds a Chemistry degree and a PhD on structure-activity relationships of amino acid derivatives. After postdoctoral work at the University of Bradford on targeted cancer therapeutics, he contributed to Alzheimer’s vaccine development at Araclon Biotech, leading to clinical success. Since 2021, he has been CTO at Certest Pharma, developing mRNA lipid-based delivery systems, resulting in four patents. Since 2022, he has contributed to mRNA drug dossiers for the European Pharmacopoeia.
Disclosure information not submitted.
Wednesday, July 16, 2025
9:00 AM – 10:00 AM EDT